A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease

Annals of Neurology

Volumn 47, Issue 4, 2000, Pages 528-531

  Morino, Hiroyuki ^a   Kawarai, Toshitaka ^a   Izumi, Yuishin ^a   Kazuta, Toshinari ^b   Oda, Masaya ^a   Komure, Osamu ^c   Udaka, Fukashi ^d   Kameyama, Masakuni ^d   Nakamura, Shigenobu ^a   Kawakami, Hideshi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

^d SUMITOMO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROPHORESIS, CAPILLARY; EXONS; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 16744368456     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200004)47:4<528::AID-ANA20>3.0.CO;2-R     Document Type: Article

References (19)

1. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-346
2. Piccini P, Burn DJ, Ceravolo R, et al. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999;45: 577-582
3. Warner TT, Schapira AH. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom. J Neurol Neurosurg Psychiatry 1998;65: 378-379
4. Smith CA, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377
5. Menegon A, Board PG, Blackburn AC, et al. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998;352:1344-1346
6. Jonsson G, Sachs C. On the mode of action of 6-hydroxydopamine. In: Jonsson G, Molmfors T, Sachs C, eds. Chemical tools in catecholamine research, vol I. Amsterdam: North-Holland, 1975:41-50
7. Burns RS, Chiueh CC, Markey SP, et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983;80:4546-4550
8. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol 1986;45:1-18
9. Cerruti C, Walther DM, Kuhar MJ, et al. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Mol Brain Res 1993;18:181-186
10. Uhl GR, Walther D, Mash D, et al. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann Neurol 1994;35:494-498
11. + transport. Synapse 1993;15:58-62
12. Kawarai T, Kawakami H, Yamamura Y, et al. Structure and organization of the gene encoding human dopamine transporter. Gene 1997;195:11-18
13. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127
14. Sambrooke J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989
15. Inazuka M, Wenz HM, Sakabe M, et al. A streamlined mutation detection system: multicolor post-PCR fluorescence labeling and single-strand conformational polymorphism analysis by capillary electrophoresis. Genome Res 1997;7:1094-1103
16. Higuchi S, Muramatsu T, Arai H, et al. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J Neural Transm Park Dis Dement Sect 1995;10:107-113
17. Plante-Bordeneuve V, Taussig D, Thomas F, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997;48:1589-1593
18. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-1797
19. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a dinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55: 181-184